DEVELOPMENT OF STEVIOSIDE LOADED PELLETS FOR REGULATING THE BLOOD GLUCOSE LEVEL IN DIABETES: IN VIVO- IN VITRO CHARACTERIZATION

Pankaj V Dangre, Vijay D Fating, Seema B Wakodkar, Mangesh D Godbole

Abstract


Stevioside is a non-caloric sweetener and used as the alternative to sugar in many countries. It has been reported to have promising antidiabetic activity. In the present investigation, we have developed a multi-particulate system of stevioside consisting of nonpareil pellets for antidiabetic patients. The drug loading on pellets was performed by solvent evaporation and suspension layering method. The loaded pellets were evaluated for yield (%), drug loading efficiency (%), flow properties and in-vitro dissolution study. The stevioside loaded pellets (STL 4) showed yields (92.36%), drug loading efficiency (86.60%), friability (0.74%), drug release (98.31%) within 60 min and good flow properties. The in vivo study indicates the significant reduction in blood glucose levels in alloxan induced diabetic rats after administration of stevioside loaded formulation (STL 4). The developed formulation of stevioside pellets can find its dual applications as a sugar substitute having the potential anti-hyperglycemic effect which can be given easily and safely to the diabetic patients.

Keywords: Stevioside; pellets; non-caloric sweetener; anti-hyperglycemic; diabetes.

 


References


Horenstein RB, Shuldiner AR. Genetics of diabetes. Rev Endocr Metab Disord 2004; 5: 25-36.

Wild S, Roglic A, Green R, King H. Global prevalence of diabetes estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-1053.

King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414-1431.

Mohan V, Sandeep S, Deepa R, Shah B, Varghese C. Epidemiology of type 2 diabetes: Indian scenario. Indian J Med Res 2007; 125: 217-230.

Barwal I, Sood A, Sharma M, Singh B, Yadav S C. Development of stevioside Pluronic-F-68 copolymer based PLA- nanoparticles as an antidiabetic nanomedicine. Colloids and surface B: Biointerface 2013; 101:510-516.

Bailey CJ, Day C. Traditional plant medicines as treatments for diabetes. Diabetes Care 1989; 12:553-564.

Madan S, Ahmad S, Singh G N, Kohli K, Kumar Y, Singh R, Garg M. Stevia rebaudiana (Bert.) Bertoni- A review. Indian J Nat Prod Resou 2010; 1(3): 267-286.

Mondaca RL, Galvez AV, Bravo LZ, Hen KA. Stevia rebaudiana Bertoni, source of a high-potency natural sweetener: A comprehensive review on the biochemical, nutritional and functional aspects. Food Chemistry 2012; 132:1121-1132.

Prakash I, DuBois GE, Cols JF, Wilkens KL, Fosdick LE. Development of rebiana, a natural, non-caloric sweetener. Food Chem Toxicol 2008; 46(7):S75-82.

Goyal SK, Samsher, Goyal RK. Stevia (stevia rebaudiana) a bio-sweetener: a review. Int J Food Sci Nutr. 2010; 61(1): 1-10.

Melis MS. Effects of chronic administration of Stevia rebaudiana on fertility in rats. J Ethanopharmacol 1999; 67:157-161.

Jeppesen PB, Gregersen S, Rolfsen SE, Jepsen M, Colombo M, Agger A, Xiao J et al. Anti-hyperglycemic and blood pressure- reducing effects of stevioside in the diabetic Goto-Kakizaki rat. Metabolism 2003; 52:372-378.

Jeppesen PB, Gregersen S, Alstrup KK, Hermansen K. Stevioside induces anti-hyperglycemic, insulinotropic and glucagonostatic effects in vivo: studies in the diabetic Goto-Kakizaki (GK) rats. Phytomedicine 2002; 9:9-14.

Kujur RS, Singh V, Ram M, Yadava HN, Singh KK, Kumari S, Roy BK. Anti-diabetic activity and phytochemical screening of crude extract of Stevia rebaudiana in alloxan induced diabetic rats. Pharmacog Res 2010; 2:258-263.

Geuns JM. Stevioside. Phytochemistry 2013; 64:913-921.

Chatsudthipong V, Muanprasat C. Stevioside and related compounds: Therapeutic benefits beyond sweetness. Pharmcol Ther 2009; 121(1):41-54.

Roberts A, Munro I. Stevioside and related compounds: Therapeutic benefits beyond sweetness. Pharmcol Ther 2009; 122(3):e1-e2.

Jeppesen PB, Gregersen S, Poulsen CR, Hermansen K. Stevioside acts directly on pancreatic beta cells to secrete insulin: action independent of cyclic adenosine monophophate and adenosine triphosphate- sensitive K+ channel activity. Metabolism 2000; 49:208-214.

Laila F, Chandran SS. Multiparticulate formulation approach to colon specific drug delivery: current perspectives. J Pharm Sci 2006; 9(3): 327-338.

Aulton ME. Pharmaceutics: The Science of Dosage Form Design. 2nd ed. Churchill-Livingstone, London. 2002. p.205-206.

Sinko P J. Martin’s. Physical Pharmacy and Pharmaceutical Sciences. 5th ed. Lippincott Williams & Wilkins; Philadelphia. 2007. p. 553-556.

Orhan N, Aslan M, Orhan DD, Ergun F, Yesilada E. In-vivo assessment antidiabetic and antioxidant activities of grapevine leaves (vitis vinifera) in diabetic rats. J Ethanopharmacol. 2006; 108; 280-286.

Note for guidance on stability testing. Stability testing of new drug substances and products; available from: URL: http://www.tga.gov. access on 12/12/2016.


Full Text: PDF

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.

footer_848
ISSN: 2250-1177  This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License.